K2B Therapeutics
Biotechnology Research
Cambridge, Ma, United States
10 employees
- Employees
- 10
- Contacts
- 2
- Emails
- 2
- Phones
- 2
K2B Therapeutics Overview
- Headquarters
- Cambridge, Ma, United States
- Industry
- Biotechnology Research
- Employees
- 10
- Founded
- 2021
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About K2B Therapeutics
K2B Therapeutics is developing protein-drug/siRNA conjugates with the potential for tumor-agnostic treatment of cancer. Our team believes that K2B's conjugates will revolutionize cancer therapeutics and address significant unmet need. The foundational technology was developed at KIST (Korea Institute of Science and Technology).
K2B Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
- Phone contacts
- 2
- 50.0% coverage
K2B Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Dmitry Malin | Sr. Principle Scientist, Rnai Therapy | Cambridge, Massachusetts, United States |
Email
Phone
|
| Joe Nabhan | Cso at Protein-drug Conjugate Newco |
View
|
|
| Wendy Zhao | Drug Discovery - Preclinical - Gene | United States |
View
|
| Hikyu Lee | Technology Entrepreneur | Boston, Massachusetts, United States |
Email
Phone
|
Employees by Management Level
Individual contributor
3 profiles
Senior / Lead
1 profile
Compare Similar Companies to K2B Therapeutics
TreeFrog Therapeutics
Biotechnology Research
NextPoint Therapeutics, Inc.
Biotechnology
Kernal Biologics
Biotechnology Research
PAQ Therapeutics
Biotechnology Research
Harton
Pharmaceutical Manufacturing
Vesigen Therapeutics, Inc.
Biotechnology Research
Stipple Bio
Biotechnology Research
InnDura Therapeutics
Biotechnology
March Therapeutics
Biotechnology
Fletcher Biosciences
Biotechnology Research